AU2001256888A1 - Method for producing an immunotropic antiviral preparation - Google Patents

Method for producing an immunotropic antiviral preparation

Info

Publication number
AU2001256888A1
AU2001256888A1 AU2001256888A AU5688801A AU2001256888A1 AU 2001256888 A1 AU2001256888 A1 AU 2001256888A1 AU 2001256888 A AU2001256888 A AU 2001256888A AU 5688801 A AU5688801 A AU 5688801A AU 2001256888 A1 AU2001256888 A1 AU 2001256888A1
Authority
AU
Australia
Prior art keywords
producing
solution
dna
hyperchromatic
homogenate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256888A
Inventor
Valery Yurevich Kaplin
Elli Nikolaevna Kaplina
Alexandra Yurevna Ladygina
Mihail Yurevich Vainberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Veritas SRL
Original Assignee
Veritas SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20242805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001256888(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Veritas SRL filed Critical Veritas SRL
Publication of AU2001256888A1 publication Critical patent/AU2001256888A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the chemical pharmaceutical industry, in particular to a method for producing an immunotropic preparation exhibiting a high antiviral activity with respect to RNA and DNA viruses. In order to produce the inventive preparation, fat-free sturgeon or salmon milt, or a calf thymus, or chicken blood, or porcine liver is pulverised and homogenised in a saline citrate solution. The produced homogenate is incubated in the presence of a detergent, a calcium chlorine solution being added at a high temperature. Afterwards, said homogenate is treated by ultrasound, a sorbent and detergent and concentrated, thereby producing a white amorphous deposit of DNA which has the following characteristics: a molecular mass ranging from 270 to 500 kD, a hyperchromatic action not less than 37 %, a protein content of less than 1 %. The DNA deposit is dried and the obtained powder is diluted in an aqueous solution of the following transition metal: Zn, Co, Mn, Sb, whereby a 1.5 % sterilised solution having a hyperchromatic action equal to or higher than 10 % is obtained.
AU2001256888A 2000-12-01 2001-04-24 Method for producing an immunotropic antiviral preparation Abandoned AU2001256888A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2000130036 2000-12-01
RU2000130036/14A RU2172632C1 (en) 2000-12-01 2000-12-01 Method of preparing immunotropic antivaral drug
PCT/RU2001/000171 WO2002043740A1 (en) 2000-12-01 2001-04-24 Method for producing an immunotropic antiviral preparation

Publications (1)

Publication Number Publication Date
AU2001256888A1 true AU2001256888A1 (en) 2002-06-11

Family

ID=20242805

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256888A Abandoned AU2001256888A1 (en) 2000-12-01 2001-04-24 Method for producing an immunotropic antiviral preparation

Country Status (8)

Country Link
EP (1) EP1338281B1 (en)
AT (1) ATE321132T1 (en)
AU (1) AU2001256888A1 (en)
BR (1) BR0107998A (en)
CA (1) CA2399310C (en)
DE (1) DE60118175T2 (en)
RU (1) RU2172632C1 (en)
WO (1) WO2002043740A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2309759C1 (en) * 2006-11-03 2007-11-10 Элли Николаевна Каплина Method for production of apyrogenic immunomodulating agent
RU2519349C1 (en) * 2013-02-26 2014-06-10 Государственное научное учреждение Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии Российской академии сельскохозяйственных наук (ГНУ ВНИВИПФиТ Россельхозакадемии) Method of comprehensive treatment of mastitis in lactating cows
RU2739186C1 (en) * 2020-04-21 2020-12-21 Александр Евгеньевич Ладыгин Method of producing antiviral drug

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
WO1993010793A1 (en) * 1991-12-03 1993-06-10 Jury Petrovich Vainberg Antivirus agent
US5547684A (en) * 1993-02-10 1996-08-20 Pharmec Company Cosmetic composition containing a DNA-sodium salt and methods of making and using the same
RU2005724C1 (en) * 1993-04-29 1994-01-15 Юрий Петрович Вайнберг Process of production of sodium dna salt from animal raw material and bioreactor for its realization
AU6584994A (en) * 1993-05-24 1994-12-20 Nauchno-Proizvodstvennoe Predpriyatie "Farmek" Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
RU2043767C1 (en) * 1993-05-24 1995-09-20 Научно-производственное предприятие "Фармэк" Method for suppressing human virus infection
RU2041885C1 (en) * 1993-05-31 1995-08-20 Научно-производственный центр "Фармзащита" МЗ РФ Process for sodium preparing salt powder of deoxyribonucleic acid from milt
RU2055837C1 (en) * 1994-05-31 1996-03-10 Научно-производственный центр "Фармзащита" Method for production of sterile solution of desoxyribonucleic acid sodium salt
WO1996009832A1 (en) * 1994-09-29 1996-04-04 Nauchno-Proizvodstvennoe Predpriyatie 'farmek' Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid
RU2108797C1 (en) * 1994-11-09 1998-04-20 Закрытое акционерное общество "Фаркавер" Method of dna-base antiviral preparation preparing
RU2136286C1 (en) * 1996-01-22 1999-09-10 Каплина Элли Николаевна Antiviral agent to rna- and dna-containing viruses
RU2158592C1 (en) * 1999-12-29 2000-11-10 Каплина Элли Николаевна Antiviral immunotropic agent

Also Published As

Publication number Publication date
ATE321132T1 (en) 2006-04-15
WO2002043740A1 (en) 2002-06-06
DE60118175T2 (en) 2007-01-25
RU2172632C1 (en) 2001-08-27
EP1338281B1 (en) 2006-03-22
BR0107998A (en) 2002-10-29
DE60118175D1 (en) 2006-05-11
CA2399310A1 (en) 2002-06-06
EP1338281A1 (en) 2003-08-27
EP1338281A4 (en) 2004-03-24
CA2399310C (en) 2012-09-18

Similar Documents

Publication Publication Date Title
AU2001254624A1 (en) Human coagulation factor vii variants
BR9915573A (en) Process of preparing a protein composition and infant formula containing the same
EP2228389A3 (en) Antibodies against vascular endothelial growth factor 2
JP2001515920A5 (en)
BR0007035A (en) Pest control methods for agrotides
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
HU9902655D0 (en) Pharmaceutical composition of hedgehog proteins and use thereof
AR029644A1 (en) ISOLATED PROTEIN, ISOLATED POLINUCLEOTIDE, TRANSGENIC GUEST CELL, METHOD FOR CONTROLLING A NON-MAMMAL PEST, BIOLOGICALLY PURE CULTURE
IT1301720B1 (en) AGENTS AND THEIR COMPOSITIONS FOR HAIR TREATMENT.
ATE185488T1 (en) VIRUS-PROOF BLOOD CLOTTING FACTOR XIII PREPARATION
DK0506821T3 (en) Hybrid protein C
AU2001256888A1 (en) Method for producing an immunotropic antiviral preparation
BR9908500A (en) Pelletizing process
BR0313436A (en) Food products containing animal protein and having improved moisture retention
PT1140113E (en) USE OF BISPHOSPHANTS FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS PROCESSES
ATE239494T1 (en) HEPARIN-BINDING PROTEIN FOR TREATING SEPSIS
BR9002873A (en) AQUEOUS HAIR CONDITIONING COMPOSITION AND PROCESS TO IMPROVE HAIR ELASTICITY
WO2001045738A3 (en) Use of heat shock proteins to enhance production of chemokines by a cell
AU2001232736A1 (en) Protein c derivatives
DE60222405D1 (en) PROCESS FOR IMPROVING PROTEIN PRODUCTS
BR0010222A (en) Viral Expression Vectors
BR0215274A (en) Modified netionine rich foods and their manufacturing processes
AU2001262554A1 (en) Inhibiting denaturation of nucleic acid duplexes
ATE293891T1 (en) METHOD FOR PRODUCING FEED PIECES FROM SEWAGE SLUDGE
MX9601346A (en) Novel trypanosoma cruzi antigen, and gene coding therefor; their application to the detection of chagas' disease.